
Rajcef S 250mg/125mg Injection
Marketer
Lifepure Labs Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Rajcef S 250mg/125mg Injection
Cefuroxime and Sulbactam injection (250mg/125mg) is a dual-action antibiotic used to combat a range of bacterial infections. Its mechanism involves inhibiting bacterial growth and spread. This medication must be administered solely by a qualified healthcare provider. Consistent adherence to the prescribed dosage schedule is crucial; complete the entire course of treatment, even with symptom improvement, to ensure effectiveness. Premature cessation may compromise its efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; report any worsening symptoms to your doctor. Seek immediate medical attention for allergic reactions like skin rashes, itching, swelling, or breathing difficulties. Inform your physician of all current medications, including over-the-counter drugs, before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Alcohol consumption should be avoided due to the risk of increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration are recommended for optimal recovery. Your physician may order lab tests to monitor the medication's impact.
Primary Ingredients of Rajcef S 250mg/125mg Injection
No text was provided to rewrite.
Uses of Rajcef S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Rajcef S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Rajcef S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Rajcef S 250mg/125mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
How Rajcef S 250mg/125mg Injection works:
The injectable drug Rajcef S (250mg Ceftriaxone/125mg Sulbactam) unites a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's antibacterial action disrupts bacterial cell wall synthesis, hindering their growth. Sulbactam counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Rajcef S 250mg/125mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Rajcef S (250mg/125mg) is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or absent harm to the fetus; nevertheless, clinical data from human trials are scarce.
Breast feedingCAUTION
The administration of Rajcef S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Rajcef S 250mg/125mg Injection can induce drowsiness, visual disturbances, and dizziness. Refrain from operating a vehicle if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Rajcef S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Rajcef S 250mg/125mg Injection cautiously, potentially requiring a modified dosage. Individuals with mild to moderate liver disease do not typically require dosage changes for Rajcef S 250mg/125mg Injection. Physician consultation is advised.
What if you forget to take Rajcef S 250mg/125mg Injection :
Should you forget a dose of Rajcef S 250mg/125mg Injection, seek your physician's advice.
Facts to Know About Rajcef S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
